AP982A - Quinoxalinediones. - Google Patents
Quinoxalinediones. Download PDFInfo
- Publication number
- AP982A AP982A APAP/P/1998/001201A AP9801201A AP982A AP 982 A AP982 A AP 982A AP 9801201 A AP9801201 A AP 9801201A AP 982 A AP982 A AP 982A
- Authority
- AP
- ARIPO
- Prior art keywords
- formula
- compound
- pharmaceutically acceptable
- acceptable salt
- solvate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Addiction (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Luminescent Compositions (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP1997/000995 WO1997032873A1 (en) | 1996-03-09 | 1997-02-27 | Quinoxalinediones |
GBGB9715783.8A GB9715783D0 (en) | 1997-02-27 | 1997-07-25 | Quinoxalinediones |
Publications (1)
Publication Number | Publication Date |
---|---|
AP982A true AP982A (en) | 2001-07-16 |
Family
ID=10816496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
APAP/P/1998/001201A AP982A (en) | 1997-02-27 | 1997-02-27 | Quinoxalinediones. |
Country Status (14)
Country | Link |
---|---|
US (1) | US6333326B1 (ko) |
KR (1) | KR100375112B1 (ko) |
AP (1) | AP982A (ko) |
AU (1) | AU723467B2 (ko) |
DZ (1) | DZ2437A1 (ko) |
EA (1) | EA001658B1 (ko) |
GT (1) | GT199800045A (ko) |
HK (1) | HK1025317A1 (ko) |
IL (1) | IL131120A0 (ko) |
IS (1) | IS5142A (ko) |
MA (1) | MA26474A1 (ko) |
OA (1) | OA11189A (ko) |
PL (1) | PL335501A1 (ko) |
UA (1) | UA58534C2 (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ20023763A3 (cs) * | 2000-05-19 | 2003-03-12 | Merck Patent Gmbh | Derivát triazolu |
US20040082543A1 (en) * | 2002-10-29 | 2004-04-29 | Pharmacia Corporation | Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain |
US8603980B2 (en) | 2007-01-16 | 2013-12-10 | The Johns Hopkins University | Glutamate receptor antagonists and methods of use |
CN110724124A (zh) | 2007-05-17 | 2020-01-24 | 株式会社半导体能源研究所 | 三唑衍生物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0556293A1 (en) * | 1990-10-30 | 1993-08-25 | Minnesota Mining & Mfg | PROCESS FOR THE PREPARATION OF BISPHENOL FLUORENE COMPOUNDS. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5158846A (en) | 1990-10-29 | 1992-10-27 | Olin Corporation | Electrostatic color printing system utilizing an image transfer belt |
HU221425B (en) * | 1990-11-06 | 2002-10-28 | Yamanouchi Pharma Co Ltd | Condensed pyrazine derivatives, process for their production and pharmaceutical preparations containing these compounds |
GB9605027D0 (en) * | 1996-03-09 | 1996-05-08 | Pfizer Ltd | Quinoxalinediones |
-
1997
- 1997-02-27 AP APAP/P/1998/001201A patent/AP982A/en active
-
1998
- 1998-02-24 PL PL98335501A patent/PL335501A1/xx unknown
- 1998-02-24 US US09/367,303 patent/US6333326B1/en not_active Expired - Fee Related
- 1998-02-24 UA UA99084653A patent/UA58534C2/uk unknown
- 1998-02-24 IL IL13112098A patent/IL131120A0/xx unknown
- 1998-02-24 AU AU68279/98A patent/AU723467B2/en not_active Ceased
- 1998-02-24 KR KR10-1999-7007786A patent/KR100375112B1/ko not_active IP Right Cessation
- 1998-02-24 EA EA199900688A patent/EA001658B1/ru not_active IP Right Cessation
- 1998-02-25 MA MA24980A patent/MA26474A1/fr unknown
- 1998-02-25 DZ DZ980047A patent/DZ2437A1/xx active
- 1998-02-26 GT GT199800045A patent/GT199800045A/es unknown
-
1999
- 1999-07-30 IS IS5142A patent/IS5142A/is unknown
- 1999-08-23 OA OA9900192A patent/OA11189A/en unknown
-
2000
- 2000-07-20 HK HK00104471A patent/HK1025317A1/xx not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0556293A1 (en) * | 1990-10-30 | 1993-08-25 | Minnesota Mining & Mfg | PROCESS FOR THE PREPARATION OF BISPHENOL FLUORENE COMPOUNDS. |
Also Published As
Publication number | Publication date |
---|---|
OA11189A (en) | 2003-05-14 |
UA58534C2 (uk) | 2003-08-15 |
DZ2437A1 (fr) | 2003-01-11 |
EA001658B1 (ru) | 2001-06-25 |
IS5142A (is) | 1999-07-30 |
HK1025317A1 (en) | 2000-11-10 |
MA26474A1 (fr) | 2004-12-20 |
AU723467B2 (en) | 2000-08-24 |
KR20000075717A (ko) | 2000-12-26 |
US6333326B1 (en) | 2001-12-25 |
EA199900688A1 (ru) | 2000-04-24 |
KR100375112B1 (ko) | 2003-03-08 |
IL131120A0 (en) | 2001-01-28 |
GT199800045A (es) | 1999-08-20 |
AU6827998A (en) | 1998-09-18 |
PL335501A1 (en) | 2000-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP495A (en) | Piperidine derivatives | |
JP2978566B2 (ja) | ノイロキニンレセプター拮抗薬としての5−アザビシクロ[3.1.0]ヘキシルアルキル−2−ピペリドンおよび−グルタルイミド | |
EP1716135B1 (en) | Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists | |
US6376490B1 (en) | Quinoxalinediones | |
JPH08511032A (ja) | 5−アリールインドール誘導体 | |
JP2009541463A (ja) | ピペリジンまたはピロリジンの尿素誘導体、これらの調製およびこれらの治療的使用 | |
JP2003034689A (ja) | 4−複素環式環縮合アリールピペリジン誘導体 | |
EP2623504A1 (de) | 5,6-Disubstituierte Oxindol-Derivate und ihre Verwendung zur Herstellung eines Medikaments zur Behandlung von Vasopressin-abhängigen Erkrankungen | |
TWI826406B (zh) | 作為血管升壓素V1a受體拮抗劑之三唑並苯並吖呯 | |
JP3026945B2 (ja) | 3−アザ及び3−オキサピペリドンタキキニン拮抗薬 | |
TW201722936A (zh) | Cgrp受體拮抗劑 | |
EP0973766B1 (en) | Quinoxalinediones | |
AP982A (en) | Quinoxalinediones. | |
WO2021159372A1 (zh) | Jak抑制剂在制备治疗jak激酶相关疾病药物中的应用 | |
AU688591B2 (en) | Quinoxaline derivatives useful in therapy | |
JP2022525697A (ja) | Drp1-フィラミン複合体形成阻害剤 | |
TW201726687A (zh) | N-(2-(2-胺基-6-取代-4,4a,5,6-四氫哌喃并[3,4-d][1,3]-8a(8H)-基)-噻唑-4-基)醯胺類 | |
CZ9903052A3 (cs) | Chinoxalindiony, způsoby a meziprodukty pro jejich výrobu, jejich použití, farmaceutické přípravky na jejich bázi a způsoby léčení | |
MXPA99007937A (en) | Quinoxalinediones | |
JP2002532525A (ja) | ジヒドロピリミジンおよびその使用 | |
JP2007516179A (ja) | Gタンパク質の機能を阻害するために有用な三環式アミドの代謝産物および増殖性疾患の処置方法 | |
BR112016012182B1 (pt) | Composto e seu uso |